Differentiated Thyroid Cancer (DTC)
1 competing product in clinical development for Differentiated Thyroid Cancer (DTC).
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib + Placebo | Eisai | Phase 3 | Completed | 40 |
1 competing product in clinical development for Differentiated Thyroid Cancer (DTC).
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib + Placebo | Eisai | Phase 3 | Completed | 40 |